EA029062B9 - Method of producing pharmaceutical composition and product therefrom - Google Patents
Method of producing pharmaceutical composition and product therefromInfo
- Publication number
- EA029062B9 EA029062B9 EA201300939A EA201300939A EA029062B9 EA 029062 B9 EA029062 B9 EA 029062B9 EA 201300939 A EA201300939 A EA 201300939A EA 201300939 A EA201300939 A EA 201300939A EA 029062 B9 EA029062 B9 EA 029062B9
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical composition
- product therefrom
- producing pharmaceutical
- dosage form
- proposed
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Proposed are a method of producing a pharmaceutical composition that is a solid dosage form, providing premixing an active principle, in particular a polymorphic form of imatinib mesylate, with a hydrophilic compound, and a product obtained by the proposed method. The proposed method allows to produce a solide dosage form with improved thermal stability, solubility and storage stability.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300939A EA029062B9 (en) | 2013-09-20 | 2013-09-20 | Method of producing pharmaceutical composition and product therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201300939A EA029062B9 (en) | 2013-09-20 | 2013-09-20 | Method of producing pharmaceutical composition and product therefrom |
Publications (3)
Publication Number | Publication Date |
---|---|
EA201300939A1 EA201300939A1 (en) | 2015-03-31 |
EA029062B1 EA029062B1 (en) | 2018-02-28 |
EA029062B9 true EA029062B9 (en) | 2018-05-31 |
Family
ID=52744868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201300939A EA029062B9 (en) | 2013-09-20 | 2013-09-20 | Method of producing pharmaceutical composition and product therefrom |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA029062B9 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1720853B2 (en) * | 2004-02-11 | 2023-06-28 | Natco Pharma Limited | Pharmaceutical compositions of the 2 crystalline form of imatinib mesylate for use in the treatment of chronic myelogenous leukemia |
JP2008542397A (en) * | 2005-06-03 | 2008-11-27 | エラン ファーマ インターナショナル リミテッド | Nanoparticulate Imatinib Mesylate Formulation |
US20100330130A1 (en) * | 2009-05-22 | 2010-12-30 | Actavis Group Ptc Ehf | Substantially pure imatinib or a pharmaceutically acceptable salt thereof |
-
2013
- 2013-09-20 EA EA201300939A patent/EA029062B9/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201300939A1 (en) | 2015-03-31 |
EA029062B1 (en) | 2018-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019011926A (en) | Methods useful in the synthesis of halichondrin b analogs. | |
MX2018000844A (en) | Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby. | |
UY35700A (en) | NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHYSICAL FIBROSIS | |
CR20140464A (en) | HETEROCICLYL COMPOUNDS | |
SG10201808624VA (en) | Polymorphs of selinexor | |
BR112016008576A2 (en) | STABLE AQUEOUS FORMULATIONS OF ANTIBODIES AND PHARMACEUTICAL UNIT DOSAGE FORM | |
PH12015502118A1 (en) | Pyridin-4-yl derivatives | |
EA201600124A1 (en) | NEW INDOLESINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
BR112016022394A2 (en) | PHARMACEUTICALLY ACCEPTABLE COMPOSITION, COMPOSITION IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE INJECTABLE SOLUTION, USE OF THE COMPOSITION, AND METHOD FOR PREPARING THE PHARMACEUTICALLY ACCEPTABLE INJECTABLE COMPOSITION | |
CR20150555A (en) | NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE | |
CR20120494S (en) | BLISTER PACKAGING FOR PRODUCT | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
UY35997A (en) | ISOQUINOLEINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
WO2015002755A3 (en) | Compounds for the treatment of malaria | |
EA201591150A1 (en) | SOLID UNIFORM FORM WITH HIGH CONTENT OF FEXOPHENADINE AND METHOD FOR OBTAINING IT | |
WO2015087343A3 (en) | An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof | |
EA029062B9 (en) | Method of producing pharmaceutical composition and product therefrom | |
MX362994B (en) | Pharmaceutical preparation comprising aminopyrazole derivative. | |
IN2013CH04314A (en) | ||
IN2013MU03508A (en) | ||
MX346497B (en) | Compounds for improved stem cell differentiation into hepatocytes. | |
MX2017004770A (en) | Solid forms of nilotinib hydrochloride. | |
MX2016002186A (en) | Process for preparing dronedarone and salts thereof. | |
MX2016005222A (en) | Acid dyes, process for the production thereof and their use. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TH4A | Publication of the corrected specification to eurasian patent | ||
QB4A | Registration of a licence in a contracting state |